Krsnaa Diagnostics (NSE:KRSNAA) ROC %: 7.63% (As of Mar. 2026)


NSE:KRSNAA Krsnaa Diagnostics Ltd NSE:KRSNAA
71 GF Score
Price ₹538.25
GF Value ₹898.08
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Krsnaa Diagnostics ROC %?

Krsnaa Diagnostics NSE:KRSNAA +0.13% 71 ROC % is 7.63% as of Mar. 2026. GuruFocus rates NSE:KRSNAA with a GF Score™ of 71/100 and a GF Value™ of ₹898.08 (Significantly Undervalued). The stock has 5 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Krsnaa Diagnostics's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 7.63%.

As of today (2026-06-29), Krsnaa Diagnostics's WACC % is 11.37%. Krsnaa Diagnostics's ROC % is 7.79% (calculated using TTM income statement data). Krsnaa Diagnostics earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Krsnaa Diagnostics  (NSE:KRSNAA) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Krsnaa Diagnostics's WACC % is 11.37%. Krsnaa Diagnostics's ROC % is 7.79% (calculated using TTM income statement data). Krsnaa Diagnostics earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Krsnaa Diagnostics ROC % Related Terms


Krsnaa Diagnostics ROC % Historical Data

* Premium members only.

The historical data trend for Krsnaa Diagnostics's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krsnaa Diagnostics ROC % Chart

Krsnaa Diagnostics Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC %
Get a 7-Day Free Trial 14.66 8.48 7.14 7.90 7.75

Krsnaa Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.37 8.31 9.00 6.14 7.63
NSE:KRSNAA
71GF Score
Krsnaa Diagnostics Ltd NSE:KRSNAA
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krsnaa Diagnostics ROC % Calculation

Krsnaa Diagnostics's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=1214.1 * ( 1 - 22.2% )/( (10720.08 + 13653.28)/ 2 )
=944.5698/12186.68
=7.75 %

where

Invested Capital(A: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=12815.95 - 1411.51 - ( 684.36 - max(0, 3053.88 - 4144.72+684.36))
=10720.08

Invested Capital(A: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18237.16 - 663.51 - ( 3920.37 - max(0, 2752.01 - 7383.4+3920.37))
=13653.28

Krsnaa Diagnostics's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=1291.64 * ( 1 - 19.31% )/( (0 + 13653.28)/ 1 )
=1042.224316/13653.28
=7.63 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18237.16 - 663.51 - ( 3920.37 - max(0, 2752.01 - 7383.4+3920.37))
=13653.28

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 7.63% mean?
Krsnaa Diagnostics (NSE:KRSNAA) has a ROC % of 7.63% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Krsnaa Diagnostics and its competitors.
Is Krsnaa Diagnostics' ROC % too high?
Krsnaa Diagnostics' current ROC % is 7.63%. Overall, Krsnaa Diagnostics has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' ROC % compare to TMO and DHR?
Krsnaa Diagnostics' ROC % of 7.63% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Diagnostics & Research company?
A good ROC % depends on the Medical Diagnostics & Research industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Krsnaa Diagnostics and its competitors. Krsnaa Diagnostics's current ROC % is 7.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹898.08, compared to a current price of ₹538.25 — trading 40.1% below its estimated fair value. The current ROC % is 7.63%. Krsnaa Diagnostics' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current ROC % is 7.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?

Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued. The current stock price of ₹538.25 is trading 40.1% below its estimated GF Value™ of ₹898.08. GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.

Key valuation signals for NSE:KRSNAA:

  • ROC %: 7.63%
  • GF Value™: ₹898.08 vs. price of ₹538.25 (40.1% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krsnaa Diagnostics Business Description

Other Exchanges 543328:India
Address S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad, Taluka - Haveli, Pune, MH, IND, 411 019
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
71GF Score

Get the complete analysis for NSE:KRSNAA

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹538.25
Price
₹898.08
GF Value